These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 9686639

  • 1. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
    Wilson SE, Pedersen SL, Kunich JC, Wilkins VL, Mann DL, Mazzara GP, Tartaglia J, Celum CL, Sheppard HW.
    AIDS Res Hum Retroviruses; 1998 Jul 20; 14(11):925-37. PubMed ID: 9686639
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.
    Cao H, Kanki P, Sankalé JL, Dieng-Sarr A, Mazzara GP, Kalams SA, Korber B, Mboup S, Walker BD.
    J Virol; 1997 Nov 20; 71(11):8615-23. PubMed ID: 9343219
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR, deSouza M, Chanbancherd P, Bernstein W, Birx DL, Cox JH.
    J Virol; 2002 May 20; 76(10):4971-86. PubMed ID: 11967314
    [Abstract] [Full Text] [Related]

  • 5. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.
    Kundu SK, Merigan TC.
    AIDS; 1992 Jul 20; 6(7):643-9. PubMed ID: 1354446
    [Abstract] [Full Text] [Related]

  • 6. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.
    Perales MA, Schwartz DH, Fabry JA, Lieberman J.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep 01; 10(1):27-35. PubMed ID: 7648281
    [Abstract] [Full Text] [Related]

  • 7. Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.
    Malm M, Rollman E, Ustav M, Hinkula J, Krohn K, Wahren B, Blazevic V.
    Viral Immunol; 2005 Sep 01; 18(4):678-88. PubMed ID: 16359234
    [Abstract] [Full Text] [Related]

  • 8. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
    Gómez CE, Nájera JL, Jiménez V, Bieler K, Wild J, Kostic L, Heidari S, Chen M, Frachette MJ, Pantaleo G, Wolf H, Liljeström P, Wagner R, Esteban M.
    Vaccine; 2007 Mar 01; 25(11):1969-92. PubMed ID: 17224219
    [Abstract] [Full Text] [Related]

  • 9. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes.
    Lubaki MN, Egan MA, Siliciano RF, Weinhold KJ, Bollinger RC.
    AIDS Res Hum Retroviruses; 1994 Nov 01; 10(11):1427-31. PubMed ID: 7888197
    [Abstract] [Full Text] [Related]

  • 10. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
    McAdam S, Kaleebu P, Krausa P, Goulder P, French N, Collin B, Blanchard T, Whitworth J, McMichael A, Gotch F.
    AIDS; 1998 Apr 16; 12(6):571-9. PubMed ID: 9583596
    [Abstract] [Full Text] [Related]

  • 11. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice.
    Chenciner N, Michel F, Dadaglio G, Langlade-Demoyen P, Hoffenbach A, Leroux A, Garcia-Pons F, Rautmann G, Guy B, Guillon JM.
    Eur J Immunol; 1989 Sep 16; 19(9):1537-44. PubMed ID: 2676560
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL.
    Carmichael A, Jin X, Sissons P.
    J Virol; 1996 Dec 16; 70(12):8468-76. PubMed ID: 8970969
    [Abstract] [Full Text] [Related]

  • 13. Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.
    Geels MJ, Dubey SA, Anderson K, Baan E, Bakker M, Pollakis G, Paxton WA, Shiver JW, Goudsmit J.
    J Virol; 2005 Sep 16; 79(17):11247-58. PubMed ID: 16103177
    [Abstract] [Full Text] [Related]

  • 14. Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.
    Buseyne F, Chaix ML, Fleury B, Manigart O, Burgard M, Blanche S, Rouzioux C, Rivière Y.
    Virology; 1998 Oct 25; 250(2):316-24. PubMed ID: 9792842
    [Abstract] [Full Text] [Related]

  • 15. HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins.
    Michel F, Hoffenbach A, Froussard P, Langlade-Demoyen P, Kaczorek M, Kieny MP, Plata F.
    AIDS Res Hum Retroviruses; 1992 Apr 25; 8(4):469-78. PubMed ID: 1376136
    [Abstract] [Full Text] [Related]

  • 16. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.
    Ferrari G, Humphrey W, McElrath MJ, Excler JL, Duliege AM, Clements ML, Corey LC, Bolognesi DP, Weinhold KJ.
    Proc Natl Acad Sci U S A; 1997 Feb 18; 94(4):1396-401. PubMed ID: 9037064
    [Abstract] [Full Text] [Related]

  • 17. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A, Jin X, Sissons P, Borysiewicz L.
    J Exp Med; 1993 Feb 01; 177(2):249-56. PubMed ID: 8093890
    [Abstract] [Full Text] [Related]

  • 18. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
    Hossain MS, Tomiyama H, Inagawa T, Ida S, Oka S, Takiguchi M.
    AIDS Res Hum Retroviruses; 2003 Jun 01; 19(6):503-10. PubMed ID: 12882660
    [Abstract] [Full Text] [Related]

  • 19. Multiple CTL specificities against autologous HIV-1-infected BLCLs.
    Ahearne PM, Morgan RA, Sebastian MW, Bolognesi DP, Weinhold KJ.
    Cell Immunol; 1995 Mar 01; 161(1):34-41. PubMed ID: 7867083
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group.
    Corey L, McElrath MJ, Weinhold K, Matthews T, Stablein D, Graham B, Keefer M, Schwartz D, Gorse G.
    J Infect Dis; 1998 Feb 01; 177(2):301-9. PubMed ID: 9466515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.